Bluejay Diagnostics, Inc. · NASDAQ:BJDX
Ayrton Capital LLC reported a 9.99% stake in Bluejay Diagnostics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 13, 2026
Ayrton Capital LLC reported a 9.99% stake in Bluejay Diagnostics, Inc., 107,722 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 107,722
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 9.99% | 107,722 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 9.99% | 107,722 |
| Waqas Khatri | 9.99% | 107,722 |
Source
Related
- Bluejay Diagnostics, Inc.
- Ayrton Capital LLC
- Bluejay Diagnostics, Inc. shareholders
- Form 4 · Dey Indranil · Aug 18, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Hrt Financial LP · Jul 13, 2026
- Schedule 13G · Mitchell P. Kopin · Jun 5, 2026
- Schedule 13D/A · Braeden Lichti · Jun 2, 2026